31 results
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Enters Into Cooperation Agreement With Engaged Capital
4:11pm
for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain
8-K
EX-99.1
NVRO
Nevro Corp
21 Feb 24
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:09pm
that continue to set the standard for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients
8-K
EX-99.1
NVRO
Nevro Corp
9 Jan 24
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
8:41am
. This was a difficult decision that impacts some of our team members who have been committed to our mission. We appreciate their dedication and contributions … in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary
8-K
EX-99.1
NVRO
Nevro Corp
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
the standard for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from
8-K
EX-99.1
3xdldqmz1zqqofu23
1 Nov 23
Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
4:07pm
8-K
EX-99.1
5upo d6omc
1 Aug 23
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
4:10pm
8-K
EX-99.1
idkt7 72gx6lhb044p
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
8-K
EX-99.1
3ibw 3kor43m2ouuwn0
19 Apr 23
Results of Operations and Financial Condition
5:07pm
8-K
EX-99.1
x5ucpvz 3r4
2 Nov 22
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
4:14pm
8-K
EX-99.1
wqyf89
3 Aug 22
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
vqngln0x1q5iu17 1x5
1 Aug 22
Other Events
7:11am
8-K
EX-99.1
ibj6utc
4 May 22
Nevro Reports First Quarter 2022 Financial Results, Provides Second Quarter 2022 Guidance and Reiterates Full-Year 2022 Guidance
4:18pm
8-K
EX-99.1
05m 2eh6jwq7db
23 Feb 22
Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance
12:00am
8-K
EX-99.1
m7jt7s1tu3mu79dw7
10 Jan 22
Nevro Announces Preliminary, Unaudited Fourth Quarter and Fourth Quarter 2021 Worldwide Revenue of Approximately $102.5 Million
6:12am
8-K
EX-99.1
2tlf5l7x46ohw 2e
5 May 20
Nevro Reports First Quarter 2020 Financial Results
4:16pm